Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antituberculosis agents.

M J Goldberger1

  • 1College of Physicians and Surgeons, Columbia University, New York.

The Medical Clinics of North America
|May 1, 1988
PubMed
Summary
This summary is machine-generated.

Tuberculosis is resurging globally. New chemotherapy strategies are crucial for managing this serious infectious disease, especially drug-resistant strains.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ASCPT Task Force for advancing pharmacometrics and integration into drug development.

Clinical pharmacology and therapeutics·2010
Same author

Tuberculosis symposium: emerging problems and promise.

The Journal of infectious diseases·1993
Same author

Mycobacterium avium infection and AIDS: a therapeutic dilemma in rapid evolution.

The Journal of infectious diseases·1991
Same author

Cefoxitin sodium and cephalothin in the treatment of serious infections.

The Journal of antimicrobial chemotherapy·1978
Same author

Therapy of serious infections with cefamandole.

Infection·1978
Same author

Pharmacokinetics of cefamandole in the presence of renal failure in patients undergoing hemodialysis.

Antimicrobial agents and chemotherapy·1976
Same journal

Care Transitions Continue to Evolve.

The Medical clinics of North America·2026
Same journal

Navigating the Gaps: A Comprehensive Overview of Care Transitions Across the Continuum.

The Medical clinics of North America·2026
Same journal

Care Transitions and Value-Based Payment Models in the United States.

The Medical clinics of North America·2026
Same journal

Technology and Innovation in Care Transitions: Imagining the Future of Postdischarge Care.

The Medical clinics of North America·2026
Same journal

Primary Care, Specialists, and Hospitals: Bridging the Gaps in Communication and Coordination.

The Medical clinics of North America·2026
Same journal

Social Determinants of Health: Unique Considerations in Transitions of Care.

The Medical clinics of North America·2026
See all related articles

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Public Health

Background:

  • Tuberculosis (TB) is experiencing a significant global resurgence.
  • Previously considered a manageable disease, TB now poses a serious public health threat.
  • The rise in TB cases necessitates updated treatment and management strategies.

Purpose of the Study:

  • To review the current landscape of tuberculosis chemotherapy.
  • To highlight advancements in treating drug-resistant tuberculosis.
  • To provide insights into controlling the rising incidence of TB.

Main Methods:

  • Literature review of recent studies on tuberculosis chemotherapy.
  • Analysis of current treatment guidelines for drug-susceptible and drug-resistant TB.

Related Experiment Videos

  • Synthesis of information on emerging therapeutic approaches.

    • Main Results:

    • Tuberculosis chemotherapy remains the cornerstone of TB control.
    • Drug-resistant tuberculosis presents a major challenge, requiring novel therapeutic agents and strategies.
    • Effective management hinges on adherence to treatment protocols and development of new drugs.

    Conclusions:

    • Urgent implementation of new chemotherapy approaches is vital to combat the TB epidemic.
    • Addressing drug resistance is paramount for successful tuberculosis treatment outcomes.
    • Continued research and global collaboration are essential for TB control.